Alnylam Pharmaceuticals
ALNY
#447
Rank
HK$410.53 B
Marketcap
HK$3,107
Share price
-2.02%
Change (1 day)
65.03%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company